FDA Drugs (New Approvals & NDA)Original article
FDA Approves First Generics of Gilotrif (afatinib) Tablets
RegulatoryapprovedGILOTRIFPositive
AI Analysis
Summary
The FDA approved the first generic versions of Gilotrif (afatinib) tablets for treating patients with metastatic NSCLC with non-resistant EGFR mutations. This regulatory approval marks entry of generics into the afatinib market.
Outcome Details
FDA approved the first generic versions of afatinib tablets
Importance:6/10
Sentiment:
0.50
FDA approvalgeneric drugNSCLCafatinibEGFR mutations
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 14, 2026 7:55 PM